AMCIL posted a modest 3.6% net profit increase to $6.9 million for FY2026 despite a 10% portfolio loss. The company cut total dividends to 4.0 cents per share, reflecting market headwinds and portfolio repositioning.
- Net profit rises 3.6% to $6.9 million
- Portfolio return slides 10% versus ASX 200’s 7.2% gain
- Total dividends fall to 4.0 cents per share
- Significant portfolio reshuffle with key disposals and new buys
- Net tangible assets per share drop to $1.08 before tax
Profit Growth Masks Portfolio Underperformance
AMCIL Limited (ASX:AMH) managed to eke out a 3.6% increase in net profit to $6.9 million for the year ended 30 June 2026, but the headline masks a challenging investment environment. The company’s portfolio returned a negative 10.0% including franking credits, sharply lagging the S&P/ASX 200 Accumulation Index’s 7.2% gain over the same period. This divergence highlights the impact of AMCIL’s sector positioning and stock selection amid a volatile market.
Dividend Cut Reflects Capital Gains Sourcing and Market Pressures
AMCIL declared a fully franked final dividend of 2.5 cents per share plus a special dividend of 0.5 cents per share, bringing total dividends for the year to 4.0 cents per share, down from 6.5 cents in FY2025. The Board elected to source 1.5 cents per share of the final and special dividends from capital gains, enabling some shareholders to claim tax deductions. The dividend cut follows a subdued revenue increase to $9.3 million and reflects the company’s cautious capital management amid portfolio losses.
Portfolio Adjustments Amid Sector Headwinds
The year saw AMCIL actively reshape its portfolio, exiting several holdings including Westpac Banking Corporation, National Australia Bank, REA Group, WiseTech Global, and a number of smaller companies such as EQT Holdings and IDP Education. These moves were driven by valuation concerns, earnings downgrades, and sectoral disruptions, notably from artificial intelligence fears impacting technology and healthcare stocks like CSL and Cochlear. New positions were initiated in Ramsay Health Care, ASX, and AUB Group, reflecting a focus on companies with turnaround potential and attractive dividend yields.
Sector Positioning and Market Risks
AMCIL’s portfolio was underweight the strong-performing Resources sector and overweight in Healthcare and Information Technology, which were the weakest sectors during the year. This sector allocation contributed to the underperformance. The company maintained a material underweight position in banks, which proved beneficial toward the end of the period as Commonwealth Bank shares declined. AMCIL’s net tangible asset backing per share fell to $1.08 before tax from $1.29 the prior year, underscoring the market valuation pressures.
Strong Cash Position and Long-Term Focus
Despite short-term setbacks, AMCIL retains a strong cash position of $16.9 million and continues to focus on quality companies with long-term growth prospects. The Board reduced the number of stocks in the portfolio to concentrate capital on high conviction holdings. AMCIL remains vigilant on earnings outlooks and market valuations, ready to capitalise on dislocations. The company will provide further insights in a shareholder webcast scheduled for 28 July 2026 and at its AGM on 1 October 2026.
Bottom Line?
AMCIL’s FY2026 results reveal a firm grappling with sector headwinds and market volatility, prompting portfolio pruning and a dividend cut that investors will scrutinise closely.
Questions in the middle?
- How will AMCIL’s portfolio repositioning affect medium-term returns amid ongoing sector volatility?
- Can the dividend sourced partially from capital gains be sustained if market conditions remain challenging?
- What impact will leadership changes and strategic adjustments have on AMCIL’s investment approach?